Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP931880.RAHNCu7TiW6A8ASaGOE-_FPyTVEBhk9RlMW1FGOJnAK3U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP931880.RAHNCu7TiW6A8ASaGOE-_FPyTVEBhk9RlMW1FGOJnAK3U130_assertion type Assertion NP931880.RAHNCu7TiW6A8ASaGOE-_FPyTVEBhk9RlMW1FGOJnAK3U130_head.
- NP931880.RAHNCu7TiW6A8ASaGOE-_FPyTVEBhk9RlMW1FGOJnAK3U130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931880.RAHNCu7TiW6A8ASaGOE-_FPyTVEBhk9RlMW1FGOJnAK3U130_provenance.
- NP931880.RAHNCu7TiW6A8ASaGOE-_FPyTVEBhk9RlMW1FGOJnAK3U130_assertion evidence source_evidence_literature NP931880.RAHNCu7TiW6A8ASaGOE-_FPyTVEBhk9RlMW1FGOJnAK3U130_provenance.
- NP931880.RAHNCu7TiW6A8ASaGOE-_FPyTVEBhk9RlMW1FGOJnAK3U130_assertion SIO_000772 21527531 NP931880.RAHNCu7TiW6A8ASaGOE-_FPyTVEBhk9RlMW1FGOJnAK3U130_provenance.
- NP931880.RAHNCu7TiW6A8ASaGOE-_FPyTVEBhk9RlMW1FGOJnAK3U130_assertion wasDerivedFrom befree-20140225 NP931880.RAHNCu7TiW6A8ASaGOE-_FPyTVEBhk9RlMW1FGOJnAK3U130_provenance.
- NP931880.RAHNCu7TiW6A8ASaGOE-_FPyTVEBhk9RlMW1FGOJnAK3U130_assertion wasGeneratedBy ECO_0000203 NP931880.RAHNCu7TiW6A8ASaGOE-_FPyTVEBhk9RlMW1FGOJnAK3U130_provenance.